Correlation Between Day One and Alto Neuroscience,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Alto Neuroscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Alto Neuroscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Alto Neuroscience,, you can compare the effects of market volatilities on Day One and Alto Neuroscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Alto Neuroscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Alto Neuroscience,.

Diversification Opportunities for Day One and Alto Neuroscience,

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Day and Alto is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Alto Neuroscience, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alto Neuroscience, and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Alto Neuroscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alto Neuroscience, has no effect on the direction of Day One i.e., Day One and Alto Neuroscience, go up and down completely randomly.

Pair Corralation between Day One and Alto Neuroscience,

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.72 times more return on investment than Alto Neuroscience,. However, Day One Biopharmaceuticals is 1.39 times less risky than Alto Neuroscience,. It trades about -0.02 of its potential returns per unit of risk. Alto Neuroscience, is currently generating about -0.07 per unit of risk. If you would invest  1,259  in Day One Biopharmaceuticals on November 4, 2024 and sell it today you would lose (22.00) from holding Day One Biopharmaceuticals or give up 1.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Alto Neuroscience,

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Alto Neuroscience, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Alto Neuroscience, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Alto Neuroscience, displayed solid returns over the last few months and may actually be approaching a breakup point.

Day One and Alto Neuroscience, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Alto Neuroscience,

The main advantage of trading using opposite Day One and Alto Neuroscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Alto Neuroscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will offset losses from the drop in Alto Neuroscience,'s long position.
The idea behind Day One Biopharmaceuticals and Alto Neuroscience, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Global Correlations
Find global opportunities by holding instruments from different markets